$104 Million is the total value of Healthcare Value Capital, LLC's 32 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CYTK | Exit | CYTOKINETICS INC | $0 | – | -41,666 | -100.0% | -0.17% | – |
BOTA | Exit | BIOTA PHARMACEUTIALS INC | $0 | – | -145,507 | -100.0% | -0.35% | – |
GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -50,000 | -100.0% | -0.41% | – |
IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -50,000 | -100.0% | -1.26% | – |
AMRI | Exit | ALBANY MOLECULAR RESH INCcall | $0 | – | -100,000 | -100.0% | -1.69% | – |
SUPN | Exit | SUPERNUS PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -1.84% | – |
BIS | Exit | PROSHARES TRcall | $0 | – | -200,000 | -100.0% | -2.39% | – |
SNY | Exit | SANOFIsponsored adr | $0 | – | -57,735 | -100.0% | -2.58% | – |
MRK | Exit | MERCK & CO INC NEW | $0 | – | -77,000 | -100.0% | -3.74% | – |
AUXL | Exit | AUXILIUM PHARMACEUTICALS INC | $0 | – | -229,481 | -100.0% | -3.86% | – |
IWM | Exit | ISHARESput | $0 | – | -100,000 | -100.0% | -9.96% | – |
TWM | Exit | PROSHARES TRcall | $0 | – | -300,000 | -100.0% | -10.82% | – |
SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -100,000 | -100.0% | -16.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
PFIZER INC | 19 | Q3 2021 | 17.9% |
TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-15 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-14 |
SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.